Suanfarma
Who owns Suanfarma?
Suanfarma is a Pharma company based in HQ Spain / Global presence, currently owned by ARCHIMED since 2021 and Peugeot Invest. It changed hands in 2021, when ICG sold.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Key facts
- ·Co-held by ARCHIMED and Peugeot Invest since 2021.
- ·Average hold across 2 realized cycles: 3 years.
- ·4 distinct PE sponsors across ownership cycles.
Ownership history
4 ownership periods · co-invest detected
ProA Capital sold Suanfarma to ICG in 2018 after 3 years.
More from Direct investment by Peugeot Invest
Other portfolio companies in the same fund.
France
Germany
US
LuxembourgMore PE-backed in Pharma
Comparable pharma deals from other GPs.
SpainQuestions
Who owns Suanfarma?
Suanfarma is currently owned by ARCHIMED and Peugeot Invest, through Direct investment by Peugeot Invest, since 2021.
When did ARCHIMED and 1 other acquire Suanfarma?
ARCHIMED and 1 other acquired Suanfarma in 2021.
Who did Suanfarma sell to?
ICG sold Suanfarma to ArchiMed in 2021 (Secondary). ProA Capital sold Suanfarma to ICG in 2018 (Secondary).
Who has owned Suanfarma over time?
Suanfarma has been through 4 private-equity ownership periods: ProA Capital · via ProA Capital Iberian Buyout Fund II · 2015–2018 · sold to ICG · (Secondary); ICG · via ICG Europe Fund VI · 2018–2021 · sold to ArchiMed · (Secondary); ARCHIMED · via MED III · 2021–2021; Peugeot Invest · via Direct investment by Peugeot Invest · 2021–2021.